Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation

Background. Extremes in body weight are a relative contraindication to card iac transplantation. Methods. We retrospectively reviewed 474 consecutive adult patients (377 ma le, 97 female, mean age 50.3 +/- 12.2 years), who received 444 primary and 30 heart retransplants between January of 1992 and January of 1999. Of thes e, 68 cachectic (body mass index [BMI]< 20 kg/m(2)), 113 overweight (BMI = > 27-30 kg/m(2)), and 55 morbidly obese (BMI > 30 kg/m(2)) patients were co mpared with 238 normal-weight recipients (BMI=20-27 kg/m(2)). We evaluated the influence of pretransplant BMI on morbidity and mortality after cardiac transplantation. Kaplan-Meier survival distribution and Cox proportional h azards model were used for statistical analyses. Results. Morbidly obese as well as cachectic recipients demonstrated nearly twice the 5-year mortality of normal-weight or overweight recipients (53% vs. 27%, respectively, P=0.001). An increase in mortality was seen at 30 da ys for morbidly obese and cachectic recipients (12.7% and 17.7%, respective ly) versus a 30-day mortality rate of 7.6% in normal-weight recipients. Mor bidly obese recipients experienced a shorter time to high-grade acute rejec tion (P=0.004) as well as an increased annual high-grade rejection frequenc y when compared with normal-weight recipients (P=0.001). By multivariable a nalysis, the incidence of transplant-related coronary artery disease (TCAD) was not increased in morbidly obese patients but cachectic patients had a significantly lower incidence of TCAD (P=0.05). Cachectic patients receivin g oversized donor hearts had a significantly higher postoperative mortality (P=0.02). Conclusions. The risks of cardiac transplantation are increased in both mor bidly obese and cachectic patients compared with normal-weight recipients. However, the results of cardiac transplantation in overweight patients is c omparable to that in normal-weight patients. Recipient size should be kept in mind while selecting patients and the use of oversized donors in cachect ic recipients should be avoided.